We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biomarker Identifies Lymphoma Patients Who Don’t Respond to Ibrutinib

News   Dec 07, 2020 | Original story from Penn Medicine

 
Biomarker Identifies Lymphoma Patients Who Don’t Respond to Ibrutinib
 
 
Advertisement
 

RELATED ARTICLES

Blood-Based Biomarkers Could Improve Detection of Breast Cancer

News

Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute.

READ MORE

How Do Blood Stem Cells Maintain Their Ability To Self-Renew?

News

A characteristic feature of all stem cells is their ability to self-renew. But how is this potential maintained throughout life?

READ MORE

AI Predicts Schizophrenia Symptoms in At-Risk Population

News

Researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE